Deuterated compounds as immunomodulators

Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutic...

Full description

Saved in:
Bibliographic Details
Main Authors Lui, Rebecca M, Zhang, Penglie, Zeng, Yibin, Fan, Pingchen, Mali, Venkat Reddy, Singh, Rajinder
Format Patent
LanguageEnglish
Published 07.11.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Bibliography:Application Number: US202017066986